Predicting Costs of Care Using a Pharmacy-Based Measure Risk Adjustment in a Veteran Population
Dados Bibliográficos
| ID | 9104857 |
|---|---|
| Autores | Anne E Sales (0000-0001-9360-3334, Boston University, autor correspondente), Chuan-Fen Liu, Chuan‐Fen Liu (0000-0002-6915-8194, Boston University, autor correspondente), Kevin L Sloan (Boston University, autor correspondente), Jesse Malkin, Jesse D Malkin (0000-0001-7666-1532, RAND Corporation), Paul Fishman (0000-0003-3419-4539, Group Health Cooperative), Paul A Fishman, Amy K Rosen (0000-0002-7539-7749, Boston University, autor correspondente), Susan Loveland (Bedford VA Research Corporation), W Paul Nichol (Boston University), Norman T Suzuki (Boston University, autor correspondente), Edward B Perrin (Boston University, autor correspondente), Edward Perrin, Nancy D Sharp, Nancy Sharp (Boston University, autor correspondente), Jeffrey Todd-Stenberg, Jeffrey A Todd–Stenberg (Boston University, autor correspondente) |
| Ano | 2003 |
| Volume | 41 |
| Fascículo | 6 |
| Páginas | 753-760 |
| Data de publicação | 2003-06-01 |
| Peer Reviewed | Sim |
| Open Access | Não |
| Tipo | ARTICLE |
| Periódico | Medical Care (JOURNAL) |
| Identificadores do periódico | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editora | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000069502.75914.dd |
| PMID | 12773841 |
| OpenAlex | W1979431715 |
| Idioma | EN |
| Citações recebidas | 9 |
| Referências citadas | 10 |
BACKGROUND: Although most widely used risk adjustment systems use diagnosis data to classify patients, there is growing interest in risk adjustment based on computerized pharmacy data. The Veterans Health Administration (VHA) is an ideal environment in which to test the efficacy of a pharmacy-based approach. OBJECTIVE: To examine the ability of RxRisk-V to predict concurrent and prospective costs of care in VHA and compare the performance of RxRisk-V to a simple age/gender model, the original RxRisk, and two leading diagnosis-based risk adjustment approaches: Adjusted Clinical Groups and Diagnostic Cost Groups/Hierarchical Condition Categories. METHODS: The study population consisted of 161,202 users of VHA services in Washington, Oregon, Idaho, and Alaska during fiscal years (FY) 1996 to 1998. We examined both concurrent and predictive model fit for two sequential 12-month periods (FY 98 and FY 99) with the patient-year as the unit of analysis, using split-half validation. RESULTS: Our results show that the Diagnostic Cost Group /Hierarchical Condition Categories model performs best (R2 = 0.45) among concurrent cost models, followed by ADG (0.31), RxRisk-V (0.20), and age/sex model (0.01). However, prospective cost models other than age/sex showed comparable R2: Diagnostic Cost Group /Hierarchical Condition Categories R2 = 0.15, followed by ADG (0.12), RxRisk-V (0.12), and age/sex (0.01). CONCLUSIONS: RxRisk-V is a clinically relevant, open source risk adjustment system that is easily tailored to fit specific questions, populations, or needs. Although it does not perform better than diagnosis-based measures available on the market, it may provide a reasonable alternative to proprietary systems where accurate computerized pharmacy data are available
Environmental health · Family medicine · Health care · Population · Chronic Disease Management Strategies · Demography · Electronic Health Records Systems · Medicine · Pharmaceutical Practices and Patient Outcomes · Pharmacy
Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
Line Authority for Nurse Staffing and Costs for Acute Inpatient Care
Construction and Characteristics of the RxRisk-V
The Effect of Complementary and Alternative Medicine Claims on Risk Adjustment
Predicting Healthcare Utilization Using a Pharmacy-based Metric With the WHO’s Anatomic Therapeutic Chemical Algorithm
Medicare Managed Care Enrollment by Disability-Eligible and Age-Eligible Veterans
Evaluating the Impact of Prescription Fill Rates on Risk Stratification Model Performance
Longitudinal Patterns of Spending Enhance the Ability to Predict Costly Patients
Case-Mix for Performance Management
Use of the Decision Support System for VA Cost-Effectiveness Research
Construction and Characteristics of the RxRisk-V
Development and Application of a Population-Oriented Measure of Ambulatory Care Case-Mix
Evaluating Diagnosis-Based Case-Mix Measures
Risk Adjustment Using Automated Ambulatory Pharmacy Data
A Chronic Disease Score with Empirically Derived Weights
| Obras citantes distintas | 9 |
|---|---|
| Citações por ano | 0,39 |
| Intervalo de citações | 2003 - 2018 (16) |
| Velocidade de citação | historical |
| Altamente citado | Não |
| Tipos de citação | Neutras: 8 |